Curated News
By: NewsRamp Editorial Staff
June 08, 2026
NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference
TLDR
- NeuroOne presents at Planet MicroCap, offering investors insights into their OneRF platform and upcoming milestones for competitive advantage.
- CEO Dave Rosa will deliver a presentation detailing OneRF platform commercialization updates and anticipated milestones at the conference.
- NeuroOne's electrode technology aims to reduce hospitalizations and improve outcomes for patients with neurological disorders.
- NeuroOne's OneRF platform targets brain, pain, and drug delivery, with a pre-recorded CEO interview available online.
Impact - Why it Matters
This news matters because NeuroOne's participation in the Planet MicroCap Conference signals potential advancements in neurological treatments. The OneRF® platform could revolutionize brain, pain, and drug delivery therapies, offering patients less invasive options and potentially reducing healthcare costs. For investors, it highlights a growing medtech company with FDA-cleared products and promising R&D pipelines.
Summary
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, announced its participation in the Planet MicroCap Las Vegas 2026 Conference scheduled for June 17-18, 2026. President and CEO Dave Rosa will attend the conference in Las Vegas, NV, where he is set to host one-on-one meetings with institutional investors and deliver a company presentation on Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time. The presentation will focus on commercialization updates and anticipated milestones for the OneRF® platform, which is designed for the treatment of the brain, pain, and advanced drug delivery. Additionally, Mr. Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference, which can be viewed here.
NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by providing both diagnostic and therapeutic functions. The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs. For more information, visit nmtc1.com.
The conference provides a platform for NeuroOne to connect with investors and showcase its innovative technologies. The webcast of the presentation can be accessed here, and the conference website is available here. For more information or to schedule a meeting with management, contact Chris Tyson at (949) 491-8235 or email NMTC@mzgroup.us. This announcement underscores NeuroOne's commitment to advancing neurological care through innovative medical technology.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, NeuroOne to Present at Planet MicroCap Las Vegas 2026 Conference
